An act to amend Section 127501.11 of the Health and Safety Code, relating to health care.
Summary
AB 278 would amend the Health and Safety Code section governing the Office of Health Care Affordability and the Health Care Affordability Board. The bill keeps the existing framework for statewide health care cost targets, sector definitions, exemptions, administrative penalties, primary care and behavioral health spending benchmarks, and related affordability policy discussions, but adds a new requirement that the board establish a Patient Advocate Advisory Standing Committee by June 1, 2026.
The new committee would be made up of representatives from patient advocacy organizations focused on chronic conditions, rare diseases, terminal illnesses, and mental or behavioral health conditions. It would be required to meet publicly at least four times per year, accept public comment, and provide annual reporting to the board on barriers to care and recommendations to improve access, quality, and affordability for the patient populations it represents. The board would then incorporate those recommendations into its own annual report.
Impact
The bill would expand the statutory duties of the Health Care Affordability Board by creating a permanent patient-focused advisory body and requiring a formal reporting channel into the board’s annual report. It would not change the underlying cost-target authority or enforcement structure, but it would add a new layer of public input and patient representation within the state’s health care affordability governance system, affecting the Office of Health Care Affordability, the board, and patient advocacy organizations.
Sentiment
The available context suggests generally favorable or at least noncontroversial treatment of the bill. There are no recorded committee transcripts or votes showing opposition, and the bill was introduced and then filed with the Chief Clerk pursuant to Joint Rule 56, indicating it did not advance further in the available record. The measure’s focus on patient advocacy, transparency, and public comment suggests an intent to broaden stakeholder participation rather than to impose new regulatory burdens on providers.
Contention
The main policy question raised by the bill is whether the board should be required to create a standing patient advocate committee, rather than relying on existing advisory or technical committees that may already include consumers, patients, labor, and health care entities. Potential points of contention could include the added administrative obligation on the board, the specific required composition of the committee, and whether the committee’s recommendations could influence affordability policy in ways that different stakeholders might view as either improving patient representation or complicating cost-control efforts. No explicit opposition is reflected in the provided record.
An act to amend Sections 103825, 103835, 103840, 103845, 103850, 103855, 124977, 124991, and 125002 of, and to add Sections 103827 and 103832 to, the Health and Safety Code, relating to public health.